Statistical analysis
Statistical analysis was performed using the SPSS Base System 10.07 J. The possible correlation between measurement items was evaluated using Pearson's correlation coefficient, and differences in the mean value were analyzed by the t test. Differences with a p value less than 0.05 were considered significant.
Results

Induction of Hsp70
In the hyperthermia group, the mean level of Hsp70 induction increased 2. was set as 1. In the non-hyperthermia group, the mean level of Hsp70 induction increased 1 .57-fold after 48 hours and 1.52-fold after 96 hours, but these increases were not significant (Fig . 1) . In the hyperthermia group, a peak value was observed after 48 hours in 3 of the 5 subjects and after 96 hours in the other 2.
Blood examinations
Biochemical examinations of blood from subjects in the hyperthermia group showed no changes in the level of 3-hydroxybutyric acid that increase usually during fatigue (Table I , Fig. 2 ). In Subject A, the Hsc70 mRNA values 48 and 96 hours after Method 1 were 0.7 and 0.9 times, respectively, and those after Method 2 were 1.46 and 1.19 times, respectively, the control value. In Subject B, the Hsc70 mRNA values 48 and 96 hours after Method 1 were 0.34 and 0.66 times, respectively, and those after Method 2 were 0.17 and 0.46 times, respectively, the control value. In Subject C, the Hsc70 mRNA values 48 and 96 hours after Method 1 were 1.1 and 2.47 times, respectively, and those after Method 2 were 0.18 and 0.93 times, respectively, the control value.
Changes in Hsp70 mRNA were compared with those in Hsc70 mRNA, which is expressed irrespective of the presence or absence of stimulation, in terms of the Hsp70 mRNA/Hsc70 mRNA ratio (Fig. 3) . A higher ratio indicated a higher amount of Hsp70 mRNA than of Hsc70 mRNA, and a higher probability of Hsp70 induction.
Blood examination in the 3 subjects
Neither the routine hematological nor the routine immunological examination showed changes common to the 3 subjects. A biochemical examination showed a higher acetoacetic acid value after Method 2 than after Method 1 in all 3 subjects (Tables II-IV , Fig. 4 ).
Discussion
As for the validity of Hsp70 induction by far-infrared hyperthermia using a Smarty, Hsp70 induction increased 2.64-fold (mean) at 48 hours and 2.07-fold at 96 hours in the far-infrared hyperthermia group, which was consistent with the Hsp70 peak 48 hours after hyperthermia reported by Ito11). Hyperthermia using a Smarty may be an effective method of Hsp70 induction. Routine hematological examinations showed similar changes in both groups, suggesting negligible influences of far-infrared hyperthermia on the body. Biochemical examinations showed no changes in ketone bodies that increase in the blood during fatigue in the hyperthermia group but a marked increase in them after 96 hours in the However, it is impossible to administer 200 mg/kg teprenone to humans. Therefore, we administered 600 mg, which is half of the upper limit permitted in tolerance tests, performed far-infrared hyperthermia 24 hours after administration, when Hsp70 induction is considered to reach a peak, and compared the Hsp70 induction by this combination method with that after hyperthermia alone. After hyperthermia alone for a total of 20 minutes (Method 1), Hsp70 did not markedly increase, but a slight Hsp70 was induced in 2 of the 3 subjects (subject B and C). However, the Hsp70 mRNA value markedly increased in 1 of the 3 subjects (subject C), suggesting Hsp70 induction at the gene level. In all 3 subjects, changes in Hsp70 mRNA were more marked than those in Hsc70 mRNA at each measurement time, suggesting an increase in Hsc70 mRNA after hyperthermia using a Smarty. After far-infrared hyperthermia in combination with teprenone administration (Method 2), Hsp70 increased 2.02-fold after 48 hours and 1.91-fold after 96 hours in 1 of the 3 subjects (subject B). However, in the other 2 subjects (subject A and C), the Hsp70 values both 48 and 96 hours after Method 2 were lower than those after Method 1, and no marked changes were observed. At the Hsp70 mRNA level, there was no marked increase, either. A comparison of changes in Hsp70 mRNA and those in Hsc70 mRNA showed no marked difference or changes suggesting Hsp70 induction. Therefore, teprenone administration at 600 mg/day might have no influence on Hsp70 induction in human lymphocytes by hyperthermia using a Smarty in this study. Blood examination showed no marked changes. However, the value of acetoacetic acid as a fatigue-associated substance was higher after Method 2 than after Method 1 in all 3 subjects. Since no decrease in acetoacetic acid was observed after hyperthermia induced using a Smarty for 20 minutes, in combination with teprenone administration, further research will be necessary for a through understanding of the process.
